Dr. Aldo Ghobriel, M.D.
What this data tells you about Dr. Ghobriel
Dr. Aldo Ghobriel is an urology physician in Rockwall, TX, with 19 years in practice. Based on federal Medicare data, Dr. Ghobriel performed 5,925 Medicare services across 3,931 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ghobriel received a total of $6,897 from 40 pharmaceutical and/or device companies across 201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ghobriel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis | 1,133 | $2 | $5 |
| Office visit, established patient (30-39 min) | 676 | $86 | $259 |
| Blood draw (venipuncture) | 589 | $8 | $17 |
| Urine culture, bacterial colony count | 560 | $8 | $16 |
| Office visit, established patient (20-29 min) | 469 | $64 | $183 |
| PSA test (prostate cancer screening) | 398 | $18 | $37 |
| Bladder ultrasound after voiding | 282 | $8 | $22 |
| Urine culture, bacterial identification | 261 | $8 | $16 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 244 | $135 | $378 |
| Chronic care management, first 20 min/month | 243 | $49 | $127 |
| New patient office visit (45-59 min) | 124 | $118 | $336 |
| Chronic care management, additional 20 min/month | 115 | $37 | $96 |
| Testosterone (hormone) level, total | 89 | $25 | $52 |
| Bacterial culture, aerobic | 89 | $8 | $16 |
| Antibiotic sensitivity test | 88 | $8 | $17 |
| Diagnostic exam of bladder and urethra using an endoscope | 85 | $177 | $495 |
| Psa (prostate specific antigen) measurement, free | 71 | $18 | $37 |
| Hospital follow-up visit, moderate complexity | 49 | $61 | $159 |
| Ceftriaxone antibiotic injection | 48 | $0 | $1 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 41 | $26 | $70 |
| Ultrasound scan of pelvic region through rectum | 35 | $94 | $282 |
| Basic metabolic blood panel | 32 | $8 | $17 |
| Hospital follow-up visit, low complexity | 28 | $39 | $98 |
| Biopsy of prostate gland | 26 | $185 | $491 |
| Comprehensive metabolic blood panel | 25 | $10 | $21 |
| Initial hospital admission, moderate complexity | 23 | $98 | $261 |
| Office visit, established patient (10-19 min) | 22 | $44 | $115 |
| Prostate cancer screening; prostate specific antigen test (psa) | 21 | $19 | $37 |
| Electronic assessment of bladder emptying | 19 | $7 | $22 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 14 | $214 | $655 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 13 | $11 | $56 |
| Imaging guidance for procedure, 60 minutes or less | 13 | $12 | $31 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ghobriel is a clinical cardiology specialist, with above-average Medicare volume (top 19% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ghobriel experienced with automated urinalysis?
Does Dr. Ghobriel receive payments from pharmaceutical companies?
How do Dr. Ghobriel's costs compare to other urology physicians in Rockwall?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology